Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Herbal nano-formulations show potential for effective skin delivery but need more research.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Monoolein-alginate beads help heal wounds by controlling moisture and effectively delivering adenosine to the skin.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The document explains various skin conditions in cats and how to diagnose and treat them.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Certain drugs can change hair color, either lightening or darkening it.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Minoxidil can help regrow hair in people with alopecia areata.